|
⚲
|
| Keyboard |
| David Brixey | |
|---|---|
| Firm | Brixey & Meyer Capital LLC |
| Address | 201 E Fourth Street, Suite 1550 Cincinnati, OH 45202 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Brixey & Meyer Capital LLC | |||||
| BMC Growth Fund IV-A | 021-423202 | Executive Officer | 64.7 M of 66.0 M |
69.7 M | |
| BMC Growth Fund IV LLC | 021-423202 | Executive Officer | 64.7 M of 66.0 M |
35.4 M | |
| BMC Mezzanine Fund I LLC | 021-449519 | Executive Officer | 5.2 M of 5.2 M |
||
| BMC Growth Fund III LLC | 021-423202 | Executive Officer | 64.7 M of 66.0 M |
57.0 M | |
| BMC Growth Fund LLC | 021-251931 | Executive Officer | 8.4 M of 20.0 M |
2.2 M | |
| BMC Growth Fund IV LLC | 021-523510 | Executive Officer | of 100.0 M |
||
| Corceuticals LLC | 021-171532 | Executive Officer | 1.1 M of 4.0 M |
||
| Nephroceuticals LLC | 021-136774 | Executive Officer | of 4.0 M |
||